Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$505K Buy
54,366
+11,797
+28% +$116K ﹤0.01% 1685
2025
Q4
$367K Sell
42,569
-3,874
-8% -$24.4K ﹤0.01% 1791
2025
Q3
$265K Buy
46,443
+8,429
+22% +$45K ﹤0.01% 1821
2025
Q2
$182K Buy
38,014
+1,384
+4% +$7.94K ﹤0.01% 1851
2025
Q1
$316K Buy
36,630
+1,518
+4% +$15.9K ﹤0.01% 1380
2024
Q4
$430K Buy
35,112
+11,771
+50% +$165K 0.01% 1141
2024
Q3
$392K Buy
+23,341
New +$384K 0.01% 972

Other funds holding NEOG

&Partners's NEOG Position: Q1 2026 in Review

&Partners increased its Neogen (NEOG) stake by 28% in Q1 2026, buying an estimated $116K and bringing the position to 54,366 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

&Partners first reported a position in NEOG in Q3 2024 and has held it in 7 quarters since. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • &Partners held 54,366 shares of Neogen worth $505K as of Q1 2026.
  • &Partners bought 11,797 Neogen shares in Q1 2026, an estimated $116K.
  • Neogen made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1685 holding.
  • &Partners first reported a position in Neogen in Q3 2024 and has held it in 7 quarters since.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.